Lexaria Bioscience (LEXX) Ownership - Who owns Lexaria Bioscience?
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LEXX showed earnings on October 29, 2025. You can read more about the earnings report here.